squamous cell carcinoma of the head and neck

You have access
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
LETICIA IGLESIAS, ROCÍO VÍLCHEZ, SANTIAGO AGUÍN, RAMÓN GARCÍA, CAROLINA PENA, ALBERTO CARRAL, GERARDO HUIDOBRO, AUREA MOLINA, JESÚS GARCÍA GÓMEZ, MARTA COVELA, MARINHA COSTA and ANA MEDINA

Anticancer Research March 2025, 45 (3) 1181-1191; DOI: https://doi.org/10.21873/anticanres.17505
Open Access
Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer
MOTOYUKI SUZUKI, YUKINORI TAKENAKA, TOSHIHIRO KISHIKAWA, YOSHIFUMI YAMAMOTO, ATSUSHI HANAMOTO, YOICHIRO TOMIYAMA, TAKAHITO FUKUSUMI, TAKAHIRO MICHIBA, NORIHIKO TAKEMOTO, SUSUMU NAKAHARA and HIDENORI INOHARA

Anticancer Research April 2021, 41 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.14973
You have access
Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck
DIRK RADES, DANIEL SEIDL, BARBARA WOLLENBERG, STEVEN E. SCHILD and SAMER G. HAKIM

Anticancer Research October 2016, 36 (10) 5463-5468;
You have access
Coordinated Expression of Cyclin-dependent Kinase-4 and its Regulators in Human Oral Tumors
MING J. POI, THOMAS J. KNOBLOCH, MARTA T. SEARS, LANA K. UHRIG, BLAKE M. WARNER, CHRISTOPHER M. WEGHORST and JUNAN LI

Anticancer Research July 2014, 34 (7) 3285-3292;

Main menu